FindTrial
Sign In

Application of platelet-rich fibrin in autologous fat transplantation

Use of platelet-rich fibrin in fat graft during facial lipostructure: a double-blind, randomized, controlled split-face clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053663
Enrollment
Unknown
Registered
2021-11-27
Start date
2017-01-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insufficient facial volume

Interventions

PRF group:Each patient received a combination of autologous fat graft and PRF on one side
control group:combined fat graft with equal volume of saline on the other side

Sponsors

Plastic Surgery, First Affiliated Hospital of Air Force Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
28 Years to 50 Years

Inclusion criteria

Inclusion criteria: In our department, patients who are required to undergo facial autologous fat transplantation are between 20 and 50 years old.

Exclusion criteria

Exclusion criteria: 1. Other treatments have been done in the operation area, or fat filling has been performed for many times; allergic constitution; 2. History of connective tissue disease; current use of hormones or chemotherapy drugs; history of diabetes; 3. Patients who cannot be followed up for more than 3 months; patients with large changes in BMI before and after surgery; 4. Can not guarantee on-time treatment, failed to cooperate.

Design outcomes

Primary

MeasureTime frame
Survival rate;the questionnaire was filled out by a plastic surgeon;satisfaction assessment;—

Countries

china

Contacts

Public ContactYi Chengang

Plastic Surgery, First Affiliated Hospital of Air Force Military Medical University

yichg@163.com+86 13319234501

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026